MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
about
Efflux-mediated drug resistance in bacteria: an updatePhenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosaInvolvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosaRole of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosisDistinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic ModelingCumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneBreakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips.Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilmsAminoglycoside modifying enzymes.Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosaNitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake.Transcriptome profiling reveals links between ParS/ParR, MexEF-OprN, and quorum sensing in the regulation of adaptation and virulence in Pseudomonas aeruginosa.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensTwo mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.Moraxella catarrhalis AcrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response.Dynamic Proteome Response of Pseudomonas aeruginosa to Tobramycin Antibiotic Treatment.Aminoglycoside resistance in Pseudomonas aeruginosa.Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.Efflux-mediated antimicrobial resistance.MexXY multidrug efflux system of Pseudomonas aeruginosa.Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in VirulenceModes and modulations of antibiotic resistance gene expression.AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELAResistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm.Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Inhaled antibiotics for gram-negative respiratory infections.Pharmacological considerations for the proper clinical use of aminoglycosides.Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.Aminoglycosides: An Overview.MexY-promoted aminoglycoside resistance in Pseudomonas aeruginosa: involvement of a putative proximal binding pocket in aminoglycoside recognition.Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants.
P2860
Q24609407-130774E2-818B-435B-9BAD-DA2208C7B7F3Q28478449-92DDFA56-166E-4DFA-BEC9-9F402AE22DF9Q28492485-5EB4F184-CEE3-4CC2-8D66-1C8FC64E9003Q28492843-83D12B0D-FC66-444F-B214-BC615CD308B9Q28550711-01F569B3-A158-42F8-89B7-1FF01B8995D6Q33267866-8EC9B847-79E9-4D22-8E9D-56C8B24EED90Q33831880-66F83A49-06A9-4BDE-9DC6-76B77459B951Q33876563-5DCEC1ED-0FBB-4DE6-BBD5-064FA1B5CA53Q33911762-A171FDDA-0DBE-4531-BB76-488CC1AB5A8DQ34042263-C891BB9A-60DB-4568-9E60-7B79072B1951Q34058108-74096BC4-39D8-4EA4-A59C-D2E8561DFBCAQ34354185-3F7B00ED-03B2-410A-ABEB-1E61A52341F4Q34509793-7FDEB4B2-DFE0-4D95-9D0E-27323613046FQ34932787-0A0263E6-3F86-430D-B493-C51F97A25600Q34986994-A8480B39-79AD-4217-BB07-0F69E829B99BQ35131669-7646F1F1-67BE-4030-9E84-52AB04F31295Q35168882-09A37976-8CEE-4BAB-914A-9EFC58370E13Q35169117-0E7375A0-71F2-4AAC-BA5F-E65BF170A92FQ35926193-7994A6D2-9821-4098-8096-8BABE95C5853Q36021296-30EDDF4F-DE16-4C92-8ED1-A7FB83DDC06CQ36095065-5EEFCEB3-0863-4A94-B0FB-D837121468CFQ36138147-BEA43423-F230-4ADE-8231-F72B89909F5EQ36450695-99A9DE5E-4C29-492B-8B30-A8C69CF1C504Q36683498-FF4C92A0-9AFD-440C-9F25-05DB51506B8BQ36708242-C4AC9DB8-3504-4833-AE35-AD86D7134849Q36720358-9D49D5FF-6FE8-45EB-A64E-7A9FA7B95D1AQ36744840-185319F9-E6C0-428D-A59E-048F9F2F5AD1Q36850490-23D79DE1-841C-4579-9757-1C55869A250AQ36933502-119730A2-AC3A-45ED-A0C4-4E1DFAAC5350Q37190771-43327924-8CD2-4D1D-871D-6EB39F28B672Q37937558-E1A61408-F304-4ED7-B1AC-A02D9CF762BFQ37956403-4322C5D9-B5CE-436F-A86D-9B73C80E0924Q38049220-9523C49E-2DF3-44A0-95FD-899FB1DADB23Q38214155-7080D30E-0499-4859-A930-DB5BF3E023EEQ38644903-5B42B170-B764-4274-9C09-99BF13AD6D6BQ38851189-B2BB60CA-2EF8-4FF0-9C81-A7502A695C5FQ38873261-94D7EF63-9ECD-4C7E-844D-70546130A0C7Q39755440-E8DA094C-0B03-4E1D-BEE5-B76BC3136B97Q39913368-46C64409-9897-4960-B9B4-12B5825E61D2Q40326667-08FC2C7A-2B18-461D-8959-9D5490E683BB
P2860
MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@en
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@nl
type
label
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@en
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@nl
prefLabel
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@en
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides.
@nl
P2093
P2860
P1476
MexXY-OprM efflux pump is nece ...... aeruginosa to aminoglycosides
@en
P2093
Angela Lee
Christelle Vogne
Didier Hocquet
Farid El Garch
Naomasa Gotoh
Olga Lomovskaya
Patrick Plésiat
P2860
P304
P356
10.1128/AAC.47.4.1371-1375.2003
P407
P50
P577
2003-04-01T00:00:00Z